SGS Exprimo focuses on the application of population PK, advanced PK/PD and drug-disease modelling & simulation to help decision making in drug development. Our experienced team can help you to make fast and well-informed decisions at all stage of drug development. Our approaches facilitate maximal use of in-house knowledge, fewer study failures and knowledge-based communication within the project team, the organization and with regulators. With many years of experience and over 300 modeling and simulation projects performed, we have built a strong platform for long term relationships with our clients, 75% is repeat business.
SGS Exprimo is part of the Life Sciences Clinical Research entity of SGS. We offer full drug development outsourcing, ranging from full early phase drug development consultancy, project management and conduct of clinical trials across Europe and Americas to biometrics, regulatory affairs, and medical writing services. For further information visit our website: www.sgs.com/cro
Please meet our consultants below, who are located all across Europe.